Exact Sciences (EXAS) Gains from Investment Securities (2016 - 2025)
Exact Sciences (EXAS) has disclosed Gains from Investment Securities for 16 consecutive years, with $55.8 million as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities rose 2087.22% to $55.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67.4 million through Dec 2025, up 1302.25% year-over-year, with the annual reading at $55.5 million for FY2025, 24566.22% up from the prior year.
- Gains from Investment Securities for Q4 2025 was $55.8 million at Exact Sciences, up from $8.7 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $55.8 million in Q4 2025, with the low at -$40.1 million in Q4 2022.
- Average Gains from Investment Securities over 5 years is -$89300.0, with a median of $656500.0 recorded in 2021.
- The sharpest move saw Gains from Investment Securities tumbled 13788.89% in 2021, then skyrocketed 2087.22% in 2025.
- Over 5 years, Gains from Investment Securities stood at $6.4 million in 2021, then crashed by 730.05% to -$40.1 million in 2022, then skyrocketed by 132.57% to $13.1 million in 2023, then tumbled by 80.45% to $2.6 million in 2024, then surged by 2087.22% to $55.8 million in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at $55.8 million, $8.7 million, and $4.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.